This study demonstrates cross-talk between kinin and AngII receptors in the mouse abdominal aorta, suggesting their joint regulation may influence pathophysiological processes like hypertension and inflammation.
Answers are grounded in this paper and cite their sources.
Animal data should not change hypertension management; leaves open kinin-AT1 receptor cross-talk as a research target.
Bradykinin (BK) is a vasorelaxant, algesic and inflammatory agent. Angiotensin II (AngII) is known to control vascular tone and promote growth, inflammation and artherogenesis. There is evidence for cross talking between BK and AngII receptors. Therefore, the effect of lack of kinin receptors was assessed in mice with genetic disruption of B(1) or B(2) and both receptors. Responsiveness of abdominal aortic rings to BK and AngII as well as the receptor gene expression of both peptides were analysed. Although no specific phenotype was displayed in the normotensive and healthy mice lacking the kinin receptors, a decreased expression level of the remaining kinin receptor mRNA was observed. AT(1) receptor mRNA level was also reduced, indicating that kinin receptors regulate AngII receptors. Downregulation of the receptors was well correlated with reduction in the reactivity of both agonists to induce contraction of aortic rings, but other signal regulations must be sought in these transgenic mice. We conclude that cross talk between kinin and AngII receptors occurs in mouse abdominal aorta and that both peptides may regulate the initiation and progression of important pathophysiological processes, such as hypertension and inflammation.
No takes yet. Share an insight, caveat, or question.
Rodrigues et al. (2009) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: